Meyer WH - Search Results

1

Phase II study of 5-fluorouracil/leucovorin for pediatric patients with malignant solid tumors.

Pratt CB, Meyer WH, Howlett N, Douglass EC, Bowman LC, Poe D, Mounce K, Kun LE, Houghton JA. Pratt CB, et al. Among authors: meyer wh. Cancer. 1994 Nov 1;74(9):2593-8. doi: 10.1002/1097-0142(19941101)74:9<2593::aid-cncr2820740930>3.0.co;2-c. Cancer. 1994. PMID: 7923016 Clinical Trial.

2

Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis.

Marina NM, Pratt CB, Rao BN, Shema SJ, Meyer WH. Marina NM, et al. Among authors: meyer wh. Cancer. 1992 Dec 1;70(11):2722-7. doi: 10.1002/1097-0142(19921201)70:11<2722::aid-cncr2820701125>3.0.co;2-s. Cancer. 1992. PMID: 1423203

3

Accumulation, intracellular metabolism, and antitumor activity of high- and low-dose methotrexate in human osteosarcoma xenografts.

Meyer WH, Loftin SK, Houghton JA, Houghton PJ. Meyer WH, et al. Cancer Commun. 1990;2(6):219-29. doi: 10.3727/095535490820874407. Cancer Commun. 1990. PMID: 1696116

4

Phase I study of flavone acetic acid (NSC 347512, LM975) in patients with pediatric malignant solid tumors.

Pratt CB, Relling MV, Meyer WH, Douglass EC, Kellie SJ, Avery L. Pratt CB, et al. Among authors: meyer wh. Am J Clin Oncol. 1991 Dec;14(6):483-6. doi: 10.1097/00000421-199112000-00005. Am J Clin Oncol. 1991. PMID: 1957836 Clinical Trial.

5

Sarcomas (other than Ewing's) of flat bones in children and adolescents. A clinicopathologic study.

Kellie SJ, Pratt CB, Parham DM, Fleming ID, Meyer WH, Rao BN. Kellie SJ, et al. Among authors: meyer wh. Cancer. 1990 Feb 15;65(4):1011-6. doi: 10.1002/1097-0142(19900215)65:4<1011::aid-cncr2820650428>3.0.co;2-#. Cancer. 1990. PMID: 2297650

6

Development and characterization of pediatric osteosarcoma xenografts.

Meyer WH, Houghton JA, Houghton PJ, Webber BL, Douglass EC, Look AT. Meyer WH, et al. Cancer Res. 1990 May 1;50(9):2781-5. Cancer Res. 1990. PMID: 2328504

7

Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumors.

Pratt CB, Goren MP, Meyer WH, Singh B, Dodge RK. Pratt CB, et al. Among authors: meyer wh. J Clin Oncol. 1990 Aug;8(8):1399-401. doi: 10.1200/JCO.1990.8.8.1399. J Clin Oncol. 1990. PMID: 2380760

8

Ifosfamide in pediatric malignant solid tumors.

Pratt CB, Douglass EC, Etcubanas EL, Goren MP, Green AA, Hayes FA, Horowitz ME, Meyer WH, Thompson EI, Wilimas JA. Pratt CB, et al. Among authors: meyer wh. Cancer Chemother Pharmacol. 1989;24 Suppl 1:S24-7. doi: 10.1007/BF00253234. Cancer Chemother Pharmacol. 1989. PMID: 2503257

9

Use of investigational drugs as initial therapy for childhood solid tumors.

Meyer WH, Houghton PJ, Horowitz ME, Etcubanas E, Pratt CB, Hayes FA, Thompson EI, Green AA, Houghton JA, Sandlund JT, et al. Meyer WH, et al. Haematol Blood Transfus. 1989;32:141-8. doi: 10.1007/978-3-642-74621-5_25. Haematol Blood Transfus. 1989. PMID: 2625241 No abstract available.

10

Phase I study of 4'-deoxydoxorubicin (esorubicin) in children with malignant solid tumors.

Pratt CB, Douglass EC, Meyer WH, Hayes FA, Horowitz ME, Thompson EI, Avery L. Pratt CB, et al. Among authors: meyer wh. Invest New Drugs. 1989 Jul;7(2-3):209-11. doi: 10.1007/BF00170859. Invest New Drugs. 1989. PMID: 2793374

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page